Eco Animal Health Share Discussion Threads

[ltinvestor] 02/12/2013 15:42

Half yearly results next week.

[audigger] 02/12/2013 14:20

The door opens to yet another income stream. Its all set-up for 2014-2015 to be a record year for the company

[smelleroo] 27/11/2013 12:39

company moving fast in the right direction - see this news out in the US the other day. am sure share price will re-rate in due course, probably with the results in the next week or so....

Pharmgate Receives Regulatory Approval for Deracin® 22% Granular, in Canada

Pharmgate LLC of Ramsey, NJ, announces the approval of its flagship product, Deracin® 22% Granular Premix containing 22% chlortetracycline, by the Veterinary Drugs Directorate of Health Canada. As the majority owned U.S. subsidiary of Jinhe Biotechnology, the largest manufacturer of chlortetracycline in the world, Pharmgate will become a significant supplier of branded chlortetracycline products in Canada.

Pharmgate LLC of Ramsey, NJ, announces the approval of its flagship product, Deracin® 22% Granular Premix containing 22% chlortetracycline, by the Veterinary Drugs Directorate of Health Canada. As the majority-owned U.S. subsidiary of Jinhe Biotechnology, the largest manufacturer of chlortetracycline in the world, Pharmgate will become a significant supplier of branded chlortetracycline products in Canada.

This generic approval carries all important label claims for the drug across livestock and poultry species. Deracin 22% Granular Premix is a high-quality, free-flowing, and dust-free granule that is manufactured and formulated in the plant that has enjoyed a 20 year history of supplying FDA-compliant products.

The product is supplied in 25kg bags and will be made available to feedmills and livestock producers in the coming months. It will be marketed by Pharmgate Animal Health, Pharmgate's marketing joint venture in North America, alongside its first product offering, Aivlosin® (tylvalosin) Water Soluble Granules, which has received considerable support from the livestock community since its launch last year.

Colin Gray, CEO of Pharmgate commented, "This is another important step in the evolution of Jinhe/Pharmgate from the largest global supplier of high quality CTC to a fully integrated and recognized animal health company. We, in company with our partners and in utilizing Pharmgate's significant supply chain, regulatory and marketing expertise look forward to building on this success in adding future complementary products over the next several years."

hxxp://nationalhogfarmer.com/pharmgate-receives-regulatory-approval-deracin-22-granular-canada

[ltinvestor] 21/11/2013 10:31

Wouldn't be too concerned but all will be revealed shortly with the half yearly results in a couple of weeks time.

[audigger] 21/11/2013 09:45

Getting a bit worrying is this latest drop.....good buying opportunity though!

[audigger] 06/11/2013 11:31

Good article LP. To have China as a key market in addition to US, EU & Russia menas the potential revenues for Aivlosin must be huge. Also interesting to see the premium product positioning in the US which will hopefully nean higher margins

[lucky_punter] 06/11/2013 08:40

Chinese tastes bode well for ECO Animal
By Philip Whiterow


It's not only metals and oil that Chinese firms are tapping into as sources of supply.
Smithfield Foods, America's largest pork supplier, has just been taken over by Shuanghui, its equivalent in China, in a US$4.7bn deal.

[ltinvestor] 29/10/2013 20:44

Great looking chart!

[audigger] 28/10/2013 13:32

Good timing IT, especially with another indication now coming online in the EU

[ltinvestor] 22/10/2013 08:27

Added yesterday as the US was always going to be the largest market for Aivlosin and it looks like this is the case.Substantial sales here will be rapidly reflected in the bottom line imho.Well below the radar at the moment but that should change in 2014.

[audigger] 16/10/2013 17:47

Almost hit 1.94 to buy. Hopefully that will be the floor from which the share price will recover

[audigger] 04/10/2013 17:40

Yes I think the way the directors have dealt with this is mindful of the impact on the share price I have no doubt the the next set of results will be very impressive. The unknown is how long it will take the share price to respond accordingly. I'm sure Mr Lawrence will be very well rewarded when the sell the Co. Clearly this was the right course of action so I have no problem with it. If I had spare cash right now I would add once the share price hits 194.

[smelleroo] 04/10/2013 16:08

money has been raised for VERY good reasons! Peter Lawrence has also bought more shares, and will now hold over 18% of EAH

[audigger] 04/10/2013 15:32

194p here we come!

[audigger] 03/10/2013 11:50

Blimey, I didn't see this coming! Explains the long slow drift of recent months. Clealry the underying business is doing well, so one has to hope this is a one-off. Arguably a good opportunity to add, but this is looking longer & longer term in terms of the pot of gold at the end of the rainbow. As previously noted on this board, it does make you wonder about the buisness model and the cut in margin taken along the distribution chain.

[audigger] 10/9/2013 21:34

Once the US market kicks-in then the future revenue & profit will increase significantly. I expect 2014-2015 revenue & profit to be a step-change from where we are today.

[cnx] 10/9/2013 01:40

I have reread the year end report and am again encouraged by their future prospects. all regions did well last year except s. America but apparently that came good in the last two months. what we need is for the chaimans encouraging remarks for the future to be turned in sustainable, growing revenues and profits.

[topvest] 09/9/2013 18:58

Yes, patience definitely needed here. I would like to see some better financial results pretty soon as well as they have been, quite frankly, a tad disappointing for far too long.

[ltinvestor] 09/9/2013 18:24

I am expecting an upward movement back to 265 and even higher with corporate action.I firmly believe that the patient shareholder will be rewarded.

[david2013] 05/9/2013 23:22

I am a long term holder since the Lawrence days and its clear that this is a very different business. Pet products to medicine for animals, that takes time licences, sales people new markets and stuff. I haven't lost any money and don't expect that I will.

[eatlessbread] 05/9/2013 21:06

@ topvest: yeah, but since 2001 they're focused on the animal drug stuff and have now got ahead of where they were in 2005!
I guess they may want to be in play?

[audigger] 02/9/2013 14:31

The slide continues despite the fact its a very blue day for the FTSE. Must be a seller afoot! I really did expect these to start to push 300 following the FDA news so the drift has been a tad disappointing. I guess we'll need to wait until the US business starts to positively impactthe bottom line, then we should move-up sharply. Is next week also ex-divi date? We may see another small drop. More patience required!

[topvest] 28/7/2013 20:16

A sobering thought though...

2001 accounts
£32m sales, £12m gross profit, £3.5m PBT

wind-on 12 years...

2013 accounts
£29m sales, £13m gross profit, £3.3m PBT

So, it's taken 10 years + to get no sales or profit growth. Slow going indeed. Continued jam tomorrow, but the business is much more valuable than 12 years ago I suppose.

[cnx] 16/7/2013 02:01

as I understand it, every invention has to be registered in each jurisdiction they seek a patent. so, it is possible there will be various termination dates

[topvest] 15/7/2013 19:14

Yes, I agree. Sounds like the patent is for quite a long time, but it would be nice to know. It might be possible to find out in the patent register.